Study: Androgen-deprivation therapy raises risk for heart disease

10/10/2007 | Washington Post, The

A U.S. study found that prostate cancer patients who underwent androgen-deprivation therapy and prostate removal surgery are more likely to die from heart disease within five years compared to patients who only had the surgery. Researchers said a decline in testosterone levels, which suggests the efficacy of ADT in inhibiting prostate cancer, could lead to metabolic syndrome that is related to cardiac complications.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC